ResearcherDalian Medical UniversityActive in the last 2 years
Lingling Si
Matched on ORCID iD 0000-0003-0161-2351; OpenAlex author ID A5043540103. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD4+ T-cell responses. Co-author DOI 10.1136/jitc-2026-016326↗
- Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines13040882↗
- Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. Biomedicines 2025, 13, 882. Co-author DOI 10.3390/biomedicines13082011↗
- GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer. Co-author DOI 10.3389/fimmu.2024.1506632↗
- Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway. Co-author DOI 10.1111/bph.13718↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yujing Xuan · 4 shared papers, 2024–2026 · strength 0.88
- Paper IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD… DOI 10.1136/jitc-2026-016326↗
- Paper Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. DOI 10.3390/biomedicines13040882↗
- Paper Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Ca… DOI 10.3390/biomedicines13082011↗
- Wenyi Yan · 4 shared papers, 2024–2026 · strength 0.88
- Paper IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD… DOI 10.1136/jitc-2026-016326↗
- Paper Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. DOI 10.3390/biomedicines13040882↗
- Paper Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Ca… DOI 10.3390/biomedicines13082011↗
- Yaohe Wang · 4 shared papers, 2024–2026 · strength 0.88
- Paper IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD… DOI 10.1136/jitc-2026-016326↗
- Paper Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. DOI 10.3390/biomedicines13040882↗
- Paper Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Ca… DOI 10.3390/biomedicines13082011↗
- Pengju Wang · 3 shared papers, 2025–2026 · strength 0.70
- Paper IL-23-engineered oncolytic vaccinia virus enhances pancreatic cancer control through inflammasome-driven Th17-skewed CD… DOI 10.1136/jitc-2026-016326↗
- Paper Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. DOI 10.3390/biomedicines13040882↗
- Paper Correction: Yan et al. Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Ca… DOI 10.3390/biomedicines13082011↗
- Yu Guo · 1 shared paper, 2026 · strength 0.25
- Pengju Wang · 1 shared paper, 2024 · strength 0.18
- Xu Han · 1 shared paper, 2017 · strength 0.07
- Jinyong Peng · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.